Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Unearned Common Stock held by the ESOP Cumulative Effect, Period of Adoption, Adjusted Balance	Unearned Common Stock held by the ESOP	Retained Earnings Cumulative effect of change in accounting principle	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Accumulated Other Comprehensive Loss Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive Loss	Cumulative effect of change in accounting principle	Cumulative Effect, Period of Adoption, Adjusted Balance	Total
Balance at Dec. 31, 2021		$ 113		$ 46,573		$ (3,709)			$ 89,627		$ (6,635)			$ 125,969
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income									2,053					2,053
Other comprehensive income (loss)											(10,939)			(10,939)
ESOP shares committed to be allocated				4		54								58
Share-based compensation expense				152										152
Balance at Mar. 31, 2022		113		46,729		(3,655)			91,680		(17,574)			117,293
Balance at Dec. 31, 2021		113		46,573		(3,709)			89,627		(6,635)			125,969
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income														4,082
Other comprehensive income (loss)														(17,126)
Balance at Jun. 30, 2022		113		46,881		(3,601)			93,709		(23,761)			113,341
Balance at Mar. 31, 2022		113		46,729		(3,655)			91,680		(17,574)			117,293
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income									2,029					2,029
Other comprehensive income (loss)											(6,187)			(6,187)
ESOP shares committed to be allocated				(1)		54								53
Share-based compensation expense				153										153
Balance at Jun. 30, 2022		113		46,881		(3,601)			93,709		(23,761)			113,341
Balance at Dec. 31, 2022	$ 113	113	$ 47,075	47,075	$ (3,491)	(3,491)	$ (633)	$ 95,991	96,624	$ (32,189)	(32,189)	$ (633)	$ 107,499	108,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income									798					798
Other comprehensive income (loss)											2,221			2,221
ESOP shares committed to be allocated				(5)		54								49
Share-based compensation expense				150										150
Balance at Mar. 31, 2023		113		47,220		(3,437)			96,789		(29,968)			110,717
Balance at Dec. 31, 2022	$ 113	113	$ 47,075	47,075	$ (3,491)	(3,491)	$ (633)	$ 95,991	96,624	$ (32,189)	(32,189)	$ (633)	$ 107,499	108,132
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income														2,229
Other comprehensive income (loss)														(1,273)
Balance at Jun. 30, 2023		111		45,976		(3,382)			98,220		(33,462)			107,463
Balance at Mar. 31, 2023		113		47,220		(3,437)			96,789		(29,968)			110,717
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income									1,431					1,431
Other comprehensive income (loss)											(3,494)			(3,494)
ESOP shares committed to be allocated				(16)		55								39
Share-based compensation expense				150										150
Repurchase of common stock		(2)		(1,378)										(1,380)
Balance at Jun. 30, 2023		$ 111		$ 45,976		$ (3,382)			$ 98,220		$ (33,462)			$ 107,463